Data from a hospital-based case-control study collected in 11 participating centers in 9 countries were analyzed to determine whether use of combined oral contraceptives alters risk of invasive squamous-cell cervical cancer.
Information on prior use of oral contraceptives, screening for cervical cancer, and suspected risk factors for this disease were ascertained from interviews of 2361 cases and 13,644 controls.
A history of smoking and anal and genital warts was obtained, and blood specimens were collected for measurement of antibodies against herpes simplex and cytomegalo viruses, from selected sub-sets of these women, as was a sexual history from interviews of husbands.
Mots-clés Pascal : Epithélioma, Col utérus, Facteur risque, Contraceptif, Voie orale, Oestroprogestatif, OMS, Epidémiologie, Femelle, Homme, Tumeur maligne, Col utérus pathologie, Appareil génital femelle pathologie, Méthode combinée
Mots-clés Pascal anglais : Carcinoma, Uterine cervix, Risk factor, Contraceptive, Oral administration, Estroprogestagen, WHO, Epidemiology, Female, Human, Malignant tumor, Uterine cervix diseases, Female genital diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0023141
Code Inist : 002B20C02. Création : 199406.